Global prevalence of young-onset dementia: a systematic review and meta-analysis
…, R Di Lorenzo, K Smith, L Flicker, MO Mol… - JAMA …, 2021 - jamanetwork.com
Importance Reliable prevalence estimates are lacking for young-onset dementia (YOD), in
which symptoms of dementia start before the age of 65 years. Such estimates are needed for …
which symptoms of dementia start before the age of 65 years. Such estimates are needed for …
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
…, S Lopez-Garcia, W Maier, M Marquié, MO Mol… - Acta …, 2022 - Springer
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF)
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …
Molecular pathways involved in frontotemporal lobar degeneration with TDP-43 proteinopathy: what can we learn from proteomics?
MO Mol, SSM Miedema, JC van Swieten… - … Journal of Molecular …, 2021 - mdpi.com
Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disorder clinically
characterized by behavioral, language, and motor symptoms, with major impact on the lives of …
characterized by behavioral, language, and motor symptoms, with major impact on the lives of …
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for …
Frontotemporal lobar degeneration with neuronal inclusions of the TAR DNA-binding
protein 43 (FTLD-TDP) represents the most common pathological subtype of FTLD. We …
protein 43 (FTLD-TDP) represents the most common pathological subtype of FTLD. We …
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease
Alzheimer’s disease (AD), the leading cause of dementia, has an estimated heritability of
approximately 70% 1 . The genetic component of AD has been mainly assessed using genome-…
approximately 70% 1 . The genetic component of AD has been mainly assessed using genome-…
Inhibition of the epigenetic suppressor EZH2 primes osteogenic differentiation mediated by BMP2
…, CR Paradise, C Galeano-Garces, MO Mol… - Journal of Biological …, 2020 - ASBMB
Bone-stimulatory therapeutics include bone morphogenetic proteins (eg BMP2), parathyroid
hormone, and antibody-based suppression of WNT antagonists. Inhibition of the epigenetic …
hormone, and antibody-based suppression of WNT antagonists. Inhibition of the epigenetic …
Mapping the genetic landscape of early-onset Alzheimer's disease in a cohort of 36 families
MO Mol, SJ van der Lee, M Hulsman… - Alzheimer's Research & …, 2022 - Springer
Background Many families with clinical early-onset Alzheimer’s disease (EOAD) remain
genetically unexplained. A combination of genetic factors is not standardly investigated. In …
genetically unexplained. A combination of genetic factors is not standardly investigated. In …
Novel TUBA4A Variant Associated With Familial Frontotemporal Dementia
MO Mol, TH Wong, S Melhem, S Basu… - Neurology …, 2021 - AAN Enterprises
Objective Despite the strong genetic component of frontotemporal dementia (FTD), a substantial
proportion of patients remain genetically unresolved. We performed an in-depth study of …
proportion of patients remain genetically unresolved. We performed an in-depth study of …
Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer's disease
Background Damaging rare variants in the TREM2, SORL1 and ABCA7 genes have been
associated with an increased risk of developing Alzheimer’s Disease (AD) with odds ratios …
associated with an increased risk of developing Alzheimer’s Disease (AD) with odds ratios …
Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological …
Genetic factors play a major role in frontotemporal dementia (FTD). The majority of FTD cannot
be genetically explained yet and it is likely that there are still FTD risk loci to be discovered…
be genetically explained yet and it is likely that there are still FTD risk loci to be discovered…
